Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor - PubMed (original) (raw)
. 1994 May 1;83(9):2594-601.
Affiliations
- PMID: 7513206
Free article
Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor
J S Miller et al. Blood. 1994.
Free article
Abstract
We have recently described a marrow stroma-dependent long-term culture system that supports differentiation of CD34+ human marrow primitive progenitors into natural killer (NK) cells. We postulate that CD7 expression may be an early event in commitment of hematopoietic progenitors to the NK lineage. Here we compare the characteristics of CD34+7- and CD34+7+ marrow cells cultivated in the stroma-based NK culture system. These CD34+ populations were further compared with a marrow derived, more committed, CD34-7+ progenitor to emphasize the continuum of NK development and to highlight differences between progenitors in our assays. No progenitor proliferated when plated in media without stroma, underscoring the importance of stroma in NK differentiation. Plating progenitor populations in interleukin-2 containing media directly on preestablished, allogeneic, irradiated marrow stroma for 5 weeks resulted in CD56+CD3- NK cells; however, characteristics of the cultured populations differed. Fold expansion and cloning efficiency of the CD34+7+ population, determined by a functional limiting dilution assay was significantly higher than of the CD34+7- or CD34+7+ populations. This suggests that the CD34+7+ population is highly enriched for an NK progenitor and a possible intermediate in NK lineage differentiation. Further dividing the CD34+7+ population by the relative fluorescence of CD7 into CD34+7+dim and CD34+7+bright populations showed that the CD34+7+bright population exhibited a significantly higher cloning frequency than parallel experiments with CD34+7+dim cells (11.8% +/- 2.4% v 2.4% +/- 0.7%, n = 6; P = .005). Plating of the more primitive CD34+7- population in a transwell system (which separates progenitors from stroma by a microporous membrane) prevents differentiation into NK cells. In contrast, plating of CD34+7+ progenitors in transwells resulted in generation of NK cells. These data suggest that primitive, but not more mature NK progenitors may require direct contact with stroma for the initial differentiation steps. Finally, differentiation of the NK progenitors in this stroma-dependent model results in expression of CD2 not present on any of the starting populations. This observation suggests that marrow stroma can stimulate CD2 expression on NK progenitors in a previously undescribed fashion that may be analogous to the thymic effect on CD2 expression in immature T lymphocytes. These observations identify early steps in the commitment of primitive marrow CD34+ hematopoietic progenitors to a lymphoid lineage and underscore the importance of coexpression of CD7 with CD34 as an early lymphoid commitment characteristic and direct progenitor-stroma interactions in this process.
Similar articles
- Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.
Lotzová E, Savary CA, Champlin RE. Lotzová E, et al. J Immunol. 1993 Jun 15;150(12):5263-9. J Immunol. 1993. PMID: 7685792 - Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
Lotzová E, Savary CA. Lotzová E, et al. Nat Immun. 1993 Jul-Oct;12(4-5):209-17. Nat Immun. 1993. PMID: 8257827 Review. - Can human hematopoietic stem cells be cultured ex vivo?
Verfaillie CM. Verfaillie CM. Stem Cells. 1994 Sep;12(5):466-76. doi: 10.1002/stem.5530120503. Stem Cells. 1994. PMID: 7528589 Review.
Cited by
- HLA-DR Expression in Natural Killer Cells Marks Distinct Functional States, Depending on Cell Differentiation Stage.
Kust SA, Ustiuzhanina MO, Streltsova MA, Shelyakin PV, Kryukov MA, Lutsenko GV, Sudarikova AV, Merzlyak EM, Britanova OV, Sapozhnikov AM, Kovalenko EI. Kust SA, et al. Int J Mol Sci. 2024 Apr 23;25(9):4609. doi: 10.3390/ijms25094609. Int J Mol Sci. 2024. PMID: 38731828 Free PMC article. - Single-cell transcriptomics in bone marrow delineates CD56dimGranzymeK+ subset as intermediate stage in NK cell differentiation.
Melsen JE, van Ostaijen-Ten Dam MM, Schoorl DJA, Schol PJ, van den Homberg DAL, Lankester AC, Lugthart G, Schilham MW. Melsen JE, et al. Front Immunol. 2022 Nov 24;13:1044398. doi: 10.3389/fimmu.2022.1044398. eCollection 2022. Front Immunol. 2022. PMID: 36505452 Free PMC article. - Preclinical and clinical studies of CAR-NK-cell therapies for malignancies.
Li H, Song W, Li Z, Zhang M. Li H, et al. Front Immunol. 2022 Oct 24;13:992232. doi: 10.3389/fimmu.2022.992232. eCollection 2022. Front Immunol. 2022. PMID: 36353643 Free PMC article. Review. - Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance.
Duan S, Liu S. Duan S, et al. Front Immunol. 2022 Mar 16;13:842746. doi: 10.3389/fimmu.2022.842746. eCollection 2022. Front Immunol. 2022. PMID: 35371060 Free PMC article. Review. - Efficient In Vitro Generation of IL-22-Secreting ILC3 From CD34+ Hematopoietic Progenitors in a Human Mesenchymal Stem Cell Niche.
Bennstein SB, Weinhold S, Degistirici Ö, Oostendorp RAJ, Raba K, Kögler G, Meisel R, Walter L, Uhrberg M. Bennstein SB, et al. Front Immunol. 2021 Dec 24;12:797432. doi: 10.3389/fimmu.2021.797432. eCollection 2021. Front Immunol. 2021. PMID: 35003122 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials